Management of Diabetic Dyslipidemia in Indians

• Statins remain first-line drugs for diabetic dyslipidemia management.

• Lowering the LDL-C to the desired level is based upon the risk category (LAI Guidelines).

• Despite adequate statin therapy, residual CHD risk factor remains.

• Nonstatin drugs to further decrease the LDL-C for the residual CHD risk factors include ezetimibe, PCSK9 inhibitors and bempedoic acid.

• As Indians have a unique lipoprotein profile with high CHD mortality in the younger age group, our aim should be to target LDL as low as possible.